Study Finds Antipsychotic Causes Breast Growth in Older Men
Ashley Lombardo · May 13, 2016
A study from the University of British Columbia linked the antipsychotic Risperdal to a higher gynecomastia risk for elderly men.
Research + FindingsBest Results for “Breast Implants”
Woman Takes Action Against Taxotere for Hair Loss Side Effect
Ashley Lombardo · October 3, 2016
Manufacturers didn't inform patients about the chemotherapy drug Taxotere's permanent hair loss risk. Ami Dodson took action and filed a lawsuit.
Legal DevelopmentsTestosterone Label Updated to Illustrate Dependency Risk
Ashley Lombardo · December 16, 2016
The Food and Drug Administration updated labeling to reflect a dependency risk linked to testosterone abuse.
FDA RegulationStudy Finds Antipsychotic Causes Breast Growth in Older Men
Ashley Lombardo · May 13, 2016
A study from the University of British Columbia linked the antipsychotic Risperdal to a higher gynecomastia risk for elderly men.
Research + FindingsWoman Takes Action Against Taxotere for Hair Loss Side Effect
Ashley Lombardo · October 3, 2016
Manufacturers didn't inform patients about the chemotherapy drug Taxotere's permanent hair loss risk. Ami Dodson took action and filed a lawsuit.
Legal DevelopmentsTestosterone Label Updated to Illustrate Dependency Risk
Ashley Lombardo · December 16, 2016
The Food and Drug Administration updated labeling to reflect a dependency risk linked to testosterone abuse.
FDA RegulationMost Recent Results for “Breast Implants”
Largest Trial Shows Vaginal Mesh Isn’t More Effective Than Standard Repair
Ashley Lombardo · January 30, 2017
In a vaginal mesh trial, researchers found the devices pose unnecessary risks and are no more effective than standard repair.
Research + FindingsFDA Updates Vaginal Mesh Warning and Risk Classification
Ashley Lombardo · October 7, 2016
The Food and Drug Administration released a vaginal mesh warning, updating the public on mesh side effects.
FDA RegulationCosmetic Safety App Rates Johnson's Baby Powder
Ashley Lombardo · August 24, 2016
The cosmetic safety app Think Dirty rated Johnson's Baby Powder, shedding new light on a common household product with hidden dangers.
MedTechStudy Finds Antipsychotic Causes Breast Growth in Older Men
Ashley Lombardo · May 13, 2016
A study from the University of British Columbia linked the antipsychotic Risperdal to a higher gynecomastia risk for elderly men.
Research + FindingsLargest Trial Shows Vaginal Mesh Isn’t More Effective Than Standard Repair
Ashley Lombardo · January 30, 2017
In a vaginal mesh trial, researchers found the devices pose unnecessary risks and are no more effective than standard repair.
Research + FindingsWoman Takes Action Against Taxotere for Hair Loss Side Effect
Ashley Lombardo · October 3, 2016
Manufacturers didn't inform patients about the chemotherapy drug Taxotere's permanent hair loss risk. Ami Dodson took action and filed a lawsuit.
Legal DevelopmentsTestosterone Label Updated to Illustrate Dependency Risk
Ashley Lombardo · December 16, 2016
The Food and Drug Administration updated labeling to reflect a dependency risk linked to testosterone abuse.
FDA RegulationFDA Updates Vaginal Mesh Warning and Risk Classification
Ashley Lombardo · October 7, 2016
The Food and Drug Administration released a vaginal mesh warning, updating the public on mesh side effects.
FDA RegulationCosmetic Safety App Rates Johnson's Baby Powder
Ashley Lombardo · August 24, 2016
The cosmetic safety app Think Dirty rated Johnson's Baby Powder, shedding new light on a common household product with hidden dangers.
MedTech